Alert: Major Price Advance (2/21/25)-Avalo Therapeutics Inc (NASDAQ: AVTX).

out_logo_500#72697.jpg

Avalo Therapeutics Inc (NASDAQ: AVTX) stock closed at $8.44 on 2/21/25 after a major increase of 17.9%. However, this advance was accompanied by unusually low trading volume at 54% of normal. The stock has been extremely weak relative to the market over the last nine months but has risen 9.9% during the last week.

out_mm#72697.jpg

Current PriceTarget Research Rating

Avalo Therapeutics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Avalo Therapeutics has a poor Appreciation Score of 30 and a very low Power Rating of 14, triggering the Lowest Value Trend Rating.

Rating Review

In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.


*